Santiago
Moreno Guillén
Catedrático/a de Universidad
Royal London Hospital
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de Royal London Hospital (9)
2022
-
The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: Regional and intra-regional differences
AIDS, Vol. 36, Núm. 3, pp. 423-435
2021
-
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort
Journal of Acquired Immune Deficiency Syndromes, Vol. 87, Núm. 2, pp. 806-817
-
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study
Annals of Internal Medicine, Vol. 174, Núm. 6, pp. 768-776
2018
-
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe
HIV Medicine, Vol. 19, Núm. 5, pp. 324-338
-
Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study
Antiviral Therapy, Vol. 23, Núm. 5, pp. 405-413
2016
-
Infection-related and -unrelated malignancies, HIV and the aging population
HIV Medicine, Vol. 17, Núm. 8, pp. 590-600
-
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study
Medicine (United States), Vol. 95, Núm. 40
2015
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Liver-related death among HIV/hepatitis C virus-co-infected individuals: Implications for the era of directly acting antivirals
AIDS, Vol. 29, Núm. 10, pp. 1205-1215